McKesson to buy Precision Medicine Group in about $2.25 billion deal
MCK•McKesson to acquire Precision Medicine Group
McKesson said on Tuesday it would buy clinical research and biopharma commercialization services provider Precision Medicine Group in a deal valued at about $2.25 billion.




